MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR

Macrocyclic inhibitors of Hepatitis C protease of formula (I) are provided, the inhibitors including a boronic acid or ester group, a macrocyclic ring of about 13 to 25 atoms including at least two amide linkages, a proline-analogous group, and a connecting segment joining moieties on either side of...

Full description

Saved in:
Bibliographic Details
Main Authors CAMPBELL, DAVID ALAN, HEPPERLE, MICHAEL, E, WINN, DAVID T, BETANCORT, JUAN MANUEL
Format Patent
LanguageEnglish
French
Published 29.01.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Macrocyclic inhibitors of Hepatitis C protease of formula (I) are provided, the inhibitors including a boronic acid or ester group, a macrocyclic ring of about 13 to 25 atoms including at least two amide linkages, a proline-analogous group, and a connecting segment joining moieties on either side of the proline-analogous group. Methods of making the HCV protease-inhibitory compounds, methods of using the compounds, formulations of the compounds:, and pharmaceutical combinations including the compounds, are provided. L'invention concerne des inhibiteurs macrocycliques de protéase d'hépatite C, les inhibiteurs comprenant un groupe acide ou ester boronique, un cycle macrocyclique d'environ 3 à 25 atomes contenant au moins deux liaisons amide, un groupe analogue à la proline, et un segment de connexion joignant des résidus sur les deux côtés du groupe analogue à la proline. L'invention concerne également des procédés de préparation des composés inhibiteurs de protéase de VHC, des formulations des composés et des combinaisons pharmaceutiques contenant les composés.
Bibliography:Application Number: WO2007US86530